DANIELLA ELLIS: Open Payments
NPI 1528149531 · ROBINSONVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 24 payments from 9 companies in 2025. Trend: 2023 $707 · 2024 $466 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $242 |
| Novo Nordisk Inc | 4 | $84 |
| Abbott Laboratories | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| PFIZER INC. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: QULIPTA, FREESTYLE LIBRE 3, Kerendia, The Cologuard Plus Collection Kit, Wegovy, NURTEC ODT, Ozempic, ZEPBOUND.
Industry payments across MS — which companies pay providers there.
